Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report

QJM. 2020 Aug 1;113(8):569-572. doi: 10.1093/qjmed/hcaa153.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • COVID-19
  • COVID-19 Drug Treatment
  • COVID-19 Testing
  • Chloroquine / administration & dosage*
  • Clinical Laboratory Techniques
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / drug therapy*
  • Cytokines / metabolism*
  • Disease Progression*
  • Drug Therapy, Combination
  • Hospitalization
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / drug therapy*
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome*

Substances

  • Antibodies, Monoclonal, Humanized
  • Cytokines
  • Chloroquine
  • tocilizumab